Global Terbinafine Hydrochloride Drug Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Terbinafine Hydrochloride Drug Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Report Code: KNJ918412 | No. of Pages: 150 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Sep-2021
Executive Summary

According to GRD Survey data, the global Terbinafine Hydrochloride Drug market was valued at  million US$ in 2020 and is expected to  million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Terbinafine Hydrochloride Drug market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Terbinafine Hydrochloride Drug in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    Topical

    Oral

Market Snapshot, By Application
    Fingernail Infection

    Toenail Infection

    Others

Market Snapshot, By Region:
    North America
        United States
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Central & South America
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Iran
        South Africa
        Israel
        Turkey
        Saudi Arabia

Main Market Players Analyzed in this report, including:
    Xiuzheng Pharmaceutical

    TEVA

    TARO

    Orchid Healthcare

    Novartis

    Jilin Wantong Group

    InvaGen Pharmaceuticals

    Hubei Hengan Fulin Pharm

    Harris Pharmaceutical

    GSK

    Glenmark

    Dr. Reddy's Laboratories

    Cussess

    CIPLA LTD

    Breckenridge Pharmaceutical

    APOTEX


The study objectives of this report are:
    To study and analyze the global Terbinafine Hydrochloride Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Terbinafine Hydrochloride Drug market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Terbinafine Hydrochloride Drug manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Terbinafine Hydrochloride Drug market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Terbinafine Hydrochloride Drug submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Terbinafine Hydrochloride Drug are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Terbinafine Hydrochloride Drug Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Terbinafine Hydrochloride Drug Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Terbinafine Hydrochloride Drug

3 Supply Chain and Manufacturing Cost Analysis
    3.1 Supply Chain Analysis
    3.2 Raw Materials and Key Suppliers Analysis
        3.2.1 Raw Materials Introduction
        3.2.1 Raw Materials Key Suppliers List
    3.3 Terbinafine Hydrochloride Drug Sales Channel and Distributors Analysis
        3.3.1 Terbinafine Hydrochloride Drug Sales Channel
        3.3.2 Terbinafine Hydrochloride Drug Distributors
    3.4 Key Buying Industries/Consumers
        3.4.1 Major Buyers in Fingernail Infection

        3.4.2 Major Buyers in Toenail Infection

    3.5 Terbinafine Hydrochloride Drug Manufacturing Cost Structure Analysis

4 Market Segment: by Type
    4.1 Terbinafine Hydrochloride Drug Type Introduction
        4.1.1 Topical

        4.1.2 Oral
    4.2 Global Terbinafine Hydrochloride Drug Sales by Type 2016-2021
    4.3 Global Terbinafine Hydrochloride Drug Revenue by Type 2016-2021
    4.4 Global Terbinafine Hydrochloride Drug Price by Type 2016-2021

5 Market Segment: by Application
    5.1 Terbinafine Hydrochloride Drug Type Introduction
        5.1.1 Fingernail Infection

        5.1.2 Toenail Infection

        5.1.3 Others
    5.2 Global Terbinafine Hydrochloride Drug Sales by Application 2016-2021
    5.3 Global Terbinafine Hydrochloride Drug Revenue by Application 2016-2021
    5.4 Global Terbinafine Hydrochloride Drug Price by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Terbinafine Hydrochloride Drug Market by Region
        6.1.1 Global Terbinafine Hydrochloride Drug Sales by Regions
        6.1.2 Global Terbinafine Hydrochloride Drug Revenue by Regions
    6.2 North America Terbinafine Hydrochloride Drug Market 2016-2021
    6.3 Europe Terbinafine Hydrochloride Drug Market 2016-2021
    6.4 Asia Pacific Terbinafine Hydrochloride Drug Market 2016-2021
    6.5 South America Terbinafine Hydrochloride Drug Market 2016-2021
    6.6 Middle East and Africa Terbinafine Hydrochloride Drug Market 2016-2021

7 North America
    7.1 North America Terbinafine Hydrochloride Drug Market by Country 2016-2021
        7.1.1 North America Terbinafine Hydrochloride Drug Sales by Country
        7.1.2 North America Terbinafine Hydrochloride Drug Revenue by Country
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Terbinafine Hydrochloride Drug Market by Country 2016-2021
        8.1.1 Europe Terbinafine Hydrochloride Drug Sales by Country
        8.1.2 Europe Terbinafine Hydrochloride Drug Revenue by Country
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Terbinafine Hydrochloride Drug Market by Country 2016-2021
        9.1.1 Asia Pacific Terbinafine Hydrochloride Drug Sales by Country
        9.1.2 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Country
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Terbinafine Hydrochloride Drug Market by Country 2016-2021
        10.1.1 South America Terbinafine Hydrochloride Drug Sales by Country
        10.1.2 South America Terbinafine Hydrochloride Drug Revenue by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Terbinafine Hydrochloride Drug Market by Country 2016-2021
        11.1.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country
        11.1.2 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Xiuzheng Pharmaceutical

        12.1.1 Xiuzheng Pharmaceutical
 Company Information
        12.1.2 Xiuzheng Pharmaceutical
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.1.3 Xiuzheng Pharmaceutical
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.1.4 Xiuzheng Pharmaceutical
 Key Development
    12.2 TEVA

        12.2.1 TEVA
 Company Information
        12.2.2 TEVA
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.2.3 TEVA
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.2.4 TEVA
 Key Development
    12.3 TARO

        12.3.1 TARO
 Company Information
        12.3.2 TARO
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.3.3 TARO
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.3.4 TARO
 Key Development
    12.4 Orchid Healthcare

        12.4.1 Orchid Healthcare
 Company Information
        12.4.2 Orchid Healthcare
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.4.3 Orchid Healthcare
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.4.4 Orchid Healthcare
 Key Development
    12.5 Novartis

        12.5.1 Novartis
 Company Information
        12.5.2 Novartis
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.5.3 Novartis
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.5.4 Novartis
 Key Development
    12.6 Jilin Wantong Group

        12.6.1 Jilin Wantong Group
 Company Information
        12.6.2 Jilin Wantong Group
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.6.3 Jilin Wantong Group
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.6.4 Jilin Wantong Group
 Key Development
    12.7 InvaGen Pharmaceuticals

        12.7.1 InvaGen Pharmaceuticals
 Company Information
        12.7.2 InvaGen Pharmaceuticals
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.7.3 InvaGen Pharmaceuticals
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.7.4 Jilin Wantong Group
 Key Development
    12.9 Harris Pharmaceutical

        12.9.1 Harris Pharmaceutical
 Company Information
        12.9.2 Harris Pharmaceutical
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.9.3 Harris Pharmaceutical
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.9.4 Harris Pharmaceutical
 Key Development
    12.8 Hubei Hengan Fulin Pharm

        12.8.1 Hubei Hengan Fulin Pharm
 Company Information
        12.8.2 Hubei Hengan Fulin Pharm
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.8.3 Hubei Hengan Fulin Pharm
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.8.4 Hubei Hengan Fulin Pharm
 Key Development
    12.11 Glenmark

        12.11.1 Glenmark
 Company Information
        12.11.2 Glenmark
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.11.3 Glenmark
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.11.4 Glenmark
 Key Development
    12.12 Dr. Reddy's Laboratories

        12.12.1 Dr. Reddy's Laboratories
 Company Information
        12.12.2 Dr. Reddy's Laboratories
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.12.3 Dr. Reddy's Laboratories
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.12.4 Dr. Reddy's Laboratories
 Key Development
    12.13 Cussess

        12.13.1 Cussess
 Company Information
        12.13.2 Cussess
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.13.3 Cussess
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.13.4 Cussess
 Key Development
    12.14 CIPLA LTD

        12.14.1 CIPLA LTD
 Company Information
        12.14.2 CIPLA LTD
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.14.3 CIPLA LTD
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.14.4 CIPLA LTD
 Key Development
    12.15 Breckenridge Pharmaceutical

        12.15.1 Breckenridge Pharmaceutical
 Company Information
        12.15.2 Breckenridge Pharmaceutical
 Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application
        12.15.3 Breckenridge Pharmaceutical
 Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021)
        12.15.4 Breckenridge Pharmaceutical
 Key Development

13 Global Terbinafine Hydrochloride Drug Market Forecast by Region by Type and by Application
    13.1 Global Terbinafine Hydrochloride Drug Sales, Revenue Forecast 2022-2027
    13.2 Global Terbinafine Hydrochloride Drug Forecast by Regions
        13.2.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Region 2022-2027
        13.2.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Region 2022-2027
    13.3 Global Terbinafine Hydrochloride Drug Forecast by Type
        13.3.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Type 2022-2027
        13.3.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Type 2022-2027
        13.3.3 Global Terbinafine Hydrochloride Drug Price Forecast by Type 2022-2027
    13.4 Global Terbinafine Hydrochloride Drug Forecast by Application
        13.4.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Application 2022-2027
        13.4.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Application 2022-2027
        13.4.3 Global Terbinafine Hydrochloride Drug Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com